Biocatalysis in the Pharmaceutical Industry: The Need for Speed.

By M. Truppo. 2017

285 citations recorded by the source corpus.

The use of biocatalysis in the pharmaceutical industry continues to expand as a result of increased access to enzymes and the ability to engineer those enzymes to meet the demands of industrial processes. However, we are still just scratching the surface of potential biocatalytic applications. The time pressures present in pharmaceutical process development are incompatible with the long lead times required for engineering a suitable biocatalyst. Dramatic increases in the speed of protein engineering are needed to deliver on the ever increasing opportunities for industrial biocatalytic processes.

Subfields: Biomedical Engineering, Molecular Biology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. R. Sheldon
2. John M. Woodley

In Molecular Biology

1. John M. Woodley
2. R. Sheldon
3. Razi Ahmad
4. M. Sardar
5. A. Demain
6. J. Adrio

Citations in the corpus

• Role of Biocatalysis in Sustainable Chemistry. (2017, background): “It is clear that the development of synthetic strategies needs to achieve a certain speed (especially in the pharmaceutical sector), 409 and it is equally clear that, although the development of new biocatalytic routes has been hugely successful in several well-publicized cases, there are also many…”